05:18 PM EDT, 08/15/2024 (MT Newswires) -- Matt Abernethy, Chief Financial Officer, on August 13, 2024, sold 14,100 shares in Neurocrine Biosciences ( NBIX ) for $2,120,347. Following the Form 4 filing with the SEC, Abernethy has control over a total of 31,528 shares of the company, with 31,528 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447524000193/xslF345X03/wk-form4_1723756315.xml